| 25. | R. Ilg, C. Burschka, D. Schepmann, B. Wünsch, R. Tacke, Synthesis and pharmacological characterization of sila-panamesine, a sila-analogue of the sigma receptor ligand panamesine (EMD 57445), Organometallics 25, 5396-5408 (2006). Lesen Sie mehr ... | 24. | J.O. Daiss, C. Burschka, J.S. Mills, J.G. Montana, G.A. Showell, J.B.H. Warneck, R. Tacke, Synthesis, crystal structure analysis, and pharmacological characterization of desmethoxy-sila-venlafaxine, derivate of the serotorin/noradrenaline reuptake inhibitor sila-venlafaxine, J. Organomet. Chem. 691, 3589-3595 (2006). Lesen Sie mehr ...
| 23. | X. Kästele, P. Klüfers, R. Tacke, Not unhydrolyzed at pH 8, Angew. Chem. 118, 3286-3288 (2006); Lesen Sie mehr... Angew. Chem. Int. Ed. 45, 3212-3214 (2006). Lesen Sie mehr ... | 22. | G.A. Showell, M.J. Barnes, J.O. Daiss, J.S. Mills, J.G. Montana, R. Tacke, J.B.H. Warneck, (R)-Sila-venlafaxine: a selective nonadrenaline reuptake inhibitor for the treatment of emesis, Bioorg. Med. Chem. Lett. 16, 2555-2558 (2006). Lesen Sie mehr ...
| 21. | J.O. Daiß, C. Burschka, J.S. Mills, J.G. Montana, G.A. Showell, J.B.H. Warneck, R. Tacke, Sila-venlafaxine, a sila-analogue of the serotonin/noradrenaline reuptake inhibitor venlafaxine: synthesis, crystal structure analysis, and pharmacological characterization, Organometallics 25, 1188-1198 (2006). Lesen Sie mehr ...
| 20. | R. Ilg, D. Troegel, C. Burschka, R. Tacke, Tetrafunctional silanes of the formula type Si(CH2X)4 (X = SAc, SH, OAc, OH, Br, I), Organometallics 25, 548–551 (2006). Lesen Sie mehr ...
| 19. | O. Seiler, M. Büttner, M. Penka, R. Tacke, Zwitterionic lambda5Si-Silicates with an SiS4C or SiS2O2C skeleton, compounds containing a square-pyramidal or trigonal-bipyramidal Si-coordination polyhedron, Organometallics 24, 6059–6052 (2005). Lesen Sie mehr ...
| 18. | S. Dragota, R. Bertermann, C. Burschka, M. Penka, R. Tacke, Diastereo- and enantiomerically pure zwitterionic spirocyclic lambda5Si-[(ammonio)methyl]silicates with an SiO2N2C skeleton containing two bidentate chelate ligands derived from alpha-amino acids, Organometallics 24, 5560-5568 (2005). Lesen Sie mehr ...
| 17. | R. Tacke, R. Bertermann, C. Burschka, S. Dragota, A zwitterionic spirocyclic pentacoordinate silicon compound synthesized in water by Si-O and Si-C bond cleavage, Angew. Chem. 117, 5426-5429 (2005); Angew. Chem. Int. Ed. 44, 5292-5295 (2005). Lesen Sie mehr ... | 16. | O. Seiler, C. Burschka, S. Metz, M. Penka, R. Tacke, Synthesis and structural characterization of neutral higher-coordinate silicon(IV) complexes with tridendate dianionic chelate ligands, Chem. Eur. J. 11, 7379-7386 (2005). Lesen Sie mehr...
| 15. | J.O. Daiss, C. Burschka, J.S. Mills, J.G. Montana, G.A. Showell, I. Fleming, C. Gaudon, D. Ivanova, H. Gronemeyer, R. Tacke, Synthesis, crystal structure analysis and pharmacological characterization of disila-bexarotene, a disila-analogue of the RXR-selective retinoid agonist bexarotene, Organometallics 24, 3192-3199 (2005). Lesen Sie mehr ...
| 14. | O. Seiler, C. Burschka, M. Fischer, M. Penka, R. Tacke, Synthesis and structural characterization of novel neutral hexacoordinate silicon(IV) complexes with SiO2N4 skeletons containing cyanato-N or thiocyanoto-N ligands, Inorg. Chem. 44, 2337-2346 (2005). Lesen Sie mehr ...
| 13. | R. Tacke, T. Schmid, M. Merget, The SiOH-containing alpha-amino acid HOMe2SiCH2CH(NH2)COOH and its immobilization on silica via an Si-O-Si linkage, Organometallics 24, 1780-1783 (2005). Lesen Sie mehr ... | 12. | O. Seiler, C. Burschka, D. Schwahn, R. Tacke, Behavior of tri(n-butyl)ammonium bis[citrato(3-)-O1,O3,O6]silicate in aqueous solution: analysis of a sol-gel process by small angle neutron scattering, Inorg. Chem. 44, 2318-2325 (2005). Lesen Sie mehr ...
| 11. | J.O. Daiß, C. Burschka, R. Tacke, Beta-Carbonylsilanes with a silacyclohexane skeleton and additional C-functionalized organyl groups at the silicon atom: synthesis, reactivity, and NMR-spectroscopic characterization, J. Organomet. Chem. 690, 678-684 (2005). Lesen Sie mehr ...
| 10. | T. Heinrich, C. Burschka, M. Penka, B. Wagner, R. Tacke, 4-silapiperidine and 4-silapiperidinium derivatives: syntheses and structural characterization, J. Organomet. Chem. 690, 33-47 (2005). Lesen Sie mehr ...
| 9. | R. Tacke, R. Bertermann, C. Burschka, S. Dragota, Hexacoordinate silicon(IV) complexes with SiO6 skeletons and multidentate ligands derived from citric acid or malic acid, Z. Anorg. Allg. Chem. 630 (2006-2012) 2004. Lesen Sie mehr ...
| 8. | R. Tacke, R. Bertermann, C. Burschka, S. Dragota, M. Penka, I. Richter, Spirocyclic zwitterionic lambda5-Si-silicates with two bidentate ligands derived from alpha-amino acids or alpha-hydroxycarboxylic acids: synthesis, structure, and stereodynamics, J. Am. Chem. Soc. 126, 14493-14505 (2004). Lesen Sie mehr ...
| 7. | J.O. Daiss, M. Albrecht, K. Mohr, R. Tacke, A novel silicon-based uncharged allosteric modulator for ligand binding to muscarinic M2 receptors: synthesis and pharmacological characterization, Organometallics 23, 6052-6057 (2004). Lesen Sie mehr ...
| 6. | J.O. Daiss, K.A. Barth, C. Burschka, P. Hey, R. Ilg, K. Klemm, I. Richter, S.A. Wagner, R. Tacke, Synthesis of the multifunctional (chloromethyl)silanes Cl2Si(CH2Cl)2, (MeO)2Si(CH2Cl)2, RSi(CH2Cl)3 (R = 2,4,6-trimethoxyphenyl), ClSi(CH2Cl)3, MeOSi(CH2Cl)3, Si(CH2Cl)4, and ClCH2CH2Si(CH2Cl)3, Organometallics 23, 5193-5197 (2004). Lesen Sie mehr ...
| 5. | J.O. Daiss, M. Penka, C. Burschka, R. Tacke, the Si-2,4,6-trimethoxyphenyl moiety as a novel protecting group in organosilicon chemistry: alternative synthesis of rac-sila-venlafaxine, Organometallics 23, 4987-4994 (2004). Lesen Sie mehr ...
| 4. | R. Tacke, T. Schmid, M. Penka, C. Burschka, W. Bains, J. Warneck, Syntheses and pharmacological properties of the histaminic H1 antagonists sila-terfenadine-A, sila-terfenadine-B, disila-terfenadine, and sila-fexofenadine: a study of C/Si bioisosterism, Organometallics 23, 4915-4923 (2004). Lesen Sie mehr ...
| 3. | R. Tacke, T. Heinrich, R. Bertermann, C. Burschka, A. Hamacher, M.U. Kassack, Sila-haloperidol: a silicon analogue of the dopamine (D2) receptor antagonist haloperidol, Organometallics 23, 4468-4477 (2004). Lesen Sie mehr ...
| 2. | T. Heinrich, C. Burschka, J. Warneck, R. Tacke, Synthesis and pharmacological properties of silicon-containing 1,4-hidyrodropyridine derivatives: calcium channel antagonists and alpha1 adrenoceptpr antagonists of the sila-niguldipine type, Organometallics 23, 361-366 (2004). Lesen Sie mehr ...
| 1. | O. Seiler, M. Penka, R. Tacke, [Benzilato(2-)-O1,O2]bis[1,3-diphenylpropane-1,3- dionato(1-)-O,O]silicon(IV): a neutral heteroleptic hexacoordinate silicon(IV) complex with an SiO6 skeleton, Inorg. Chim. Acta 357, 1955-1958 (2004). Lesen Sie mehr ... |
|